Matthias Unterhuber Profile
Matthias Unterhuber

@m_unterhuber

Followers
121
Following
631
Media
8
Statuses
108

Leipzig, Germany
Joined May 2019
Don't wanna be here? Send us removal request.
@galia0327
galia zhang
11 months
🚀 Explore the role of AI in cardiology with @JCM_MDPI special issue "Application of Artificial Intelligence in Cardiology", led by @m_unterhuber 🗓️ Submission Deadline: 31 July 2025 🌐 Learn more: https://t.co/o1dPpjGap1 #ArtificialIntelligence #Cardiology
0
1
0
@KP_Kresoja
Karl-Patrik Kresoja
2 years
In an ideal world every 💊 we prescribe prevents an event #NNT1 Not there yet, but we may have come closer Now in @eBioMedicine how to identify optimal responders to spironolactone in HFpEF a🧵 @PhilippLurz @m_unterhuber @thiele_holger https://t.co/ZqvXcqNOUN
3
13
24
@m_unterhuber
Matthias Unterhuber
3 years
Just published: ever needed a help with AI-ML in Cardiology? Let me present a review and a gentle guide for cardiologists to interpret and use ML methods! @KP_Kresoja @RoWachter @thiele_holger @PhilippLurz
@BasicResCardiol
Basic Research in Cardiology
3 years
Artificial intelligence as a cardiologist´s tool. https://t.co/t5S8pRIYyM
1
5
8
@thiele_holger
Holger Thiele
3 years
Just published our review on artificial intelligence in cardiovascular disease ⁦@BasicResCardiol⁩ ⁦@KP_Kresoja⁩ ⁦@PhilippLurz⁩ ⁦@m_unterhuber⁩ ⁦@YoungDZHK⁩ ⁦@dzhk_germany⁩ ⁦@YoungDgk
1
8
47
@PhilippLurz
Philipp Lurz
3 years
@drandrewsharp 4/4 3. Chronic TR can lead to hypercirculatory heart failure (complex cardio-hepatic-intestinal-renal-interaction). Reduced venous pressure and congestion might reverse this pathology @m_unterhuber https://t.co/jRl6ZZ0iHD Dyspnea is typical symptom in TR, so much more to learn
1
10
20
@PhilippLurz
Philipp Lurz
3 years
@drandrewsharp 3/4 TR reduction improves ventricular interaction by less RV volume and thereby more space for the LV to expand in a restricted pericardial space! ⬇️ LV filling pressures @KP_Kresoja https://t.co/LJnUTTuML1
0
7
19
@PhilippLurz
Philipp Lurz
3 years
@drandrewsharp 2/4 1. TTVR ⬇ regurgitant volume and total RV stroke volume, but ⬆️ pulmonary artery net forward flow --> ⬆️LV filling and cardiac output https://t.co/2iwFOBm1vK @kp_rommel
0
7
19
@PhilippLurz
Philipp Lurz
3 years
@drandrewsharp 1/4 in our experience improved NYHA class and less SOB more certain after TR treatment than after MR treatment. NYHA improvement has been demonstrated in pretty much every study on TTVR! Possible explanation are:
3
13
35
@m_unterhuber
Matthias Unterhuber
3 years
Very excited to contribute in @ESC_Journals’ CardioPulse: where is the combination of artificial intelligence and proteomics going and what possibilities are to be leveraged in the future? More: https://t.co/IFpGPhLGPc @KP_Kresoja @PhilippLurz @thiele_holger
Tweet card summary image
academic.oup.com
In cardiology, risk scores are used daily to estimate the cardiovascular disease (CVD) risk of a patient and eventually guide clinical decision making. To
1
13
34
@thiele_holger
Holger Thiele
3 years
Tag 2 #kfjt2022. Wie antikoagulieren bei Vorhofflimmern? ⁦@JaninePoss⁩ ⁦@KP_Kresoja⁩ ⁦@kp_rommel⁩ ⁦@mrubini⁩ ⁦@sulimov_dmitry⁩ ⁦@GerdHindricks
0
2
11
@KP_Kresoja
Karl-Patrik Kresoja
3 years
S Windecker giving an excellent talk on lifelong management of Aortic stenosis TAVI vs. sAVR or both? Live from Bern to Leipzig @ #kfjt2022 #CardioTwitter @thiele_holger @PhilippLurz @Mo_A_W @feistritzerH_J @m_unterhuber @AnneFreund3 @BlazekStephan @KardiologieHH @A_Schoeber
2
8
17
@m_unterhuber
Matthias Unterhuber
3 years
What a pleasure to see @jalurz presenting this extraordinary project as a late-breaker #hrs2022 in #SanFrancisco !!
0
0
3
@m_unterhuber
Matthias Unterhuber
3 years
Very proud to be part of this project of my friend and colleague @KP_Kresoja , exciting to see Spironolactone may play a role in #hfpef
1
1
12
@maorban
Mathias Orban
4 years
Accompanying audio commentary by Professor Fuster on the results of #MTEER for #SMR from the EuroSMR registry: https://t.co/25mhFCugwR Paper here: https://t.co/wHf9lbacVc @JACCJournals @BenediktKoell @PhilippLurz @vonBardelebenRS @thiele_holger
Tweet card summary image
jacc.org
0
4
8
@m_unterhuber
Matthias Unterhuber
4 years
A brilliant paper describing the strong correlation between procedural success and quality of life after #TTVR !
@KP_Kresoja
Karl-Patrik Kresoja
4 years
Recent data highlights systemic implications of #TR We present evidence that assessing global QoL of patients undergoing TTVR might be crucial as TTVR patients show highest ⬆️in global QoL assessments and not only cardiospecific QoL #CardioTwitter https://t.co/Sm86EGBs1i
0
1
2
@thiele_holger
Holger Thiele
4 years
CHOICE-CLOSURE just presented and simultaneously published ⁦@Mo_A_W⁩ ⁦@TCTConference⁩ ⁦@CircAHA⁩ ⁦@AGIKinterv⁩ ⁦@drnvanmieghem
2
14
71
@tony_breu
Tony Breu
4 years
1/15 Why are statins administered at night? In this tweetorial I'll discuss the mechanistic and historical reasons for the frequently used QHS dosing schedule. And why it's often unnecessary. But before we get there, I'm curious: when do you prescribe/order/take statins?
47
623
1K
@maorban
Mathias Orban
4 years
#3Decho shows that #3D right ventricular function is highly prognostic (cutoff ≈45%, confirmed Leipzig Heart Team) and decreases after tricuspid #TEER Waiting for RCT echo results @KP_Kresoja @m_unterhuber @PhilippLurz @vonBardelebenRS @jaccjournals
Tweet card summary image
jacc.org
0
4
12
@ProfMartinCowie
Martin Cowie
4 years
#ESCdigitalsummit @escardio if you missed the opening session - you can watch here. All the key themes and mutliple perspectives. @Steph_Achenbach @RobynDGallagher @AVerstrael @PaulDendale @prof_stromberg
@escardio
European Society of Cardiology
4 years
#ESCDigitalSummit Inaugural Session
1
16
50